SEC 13F Intelligence

Tyrus Capital S.a.m. / AVIR

Tyrus Capital S.a.m.’s Atea Pharmaceuticals Inc Position

Does Tyrus Capital S.a.m. own Atea Pharmaceuticals Inc (AVIR)? Yes — 1.26M shares worth $4M (+35.90% of its 13F portfolio) as of Q3 2023.

Position Value
$4M
Q3 2023
Shares
1.26M
% of Portfolio
+35.90%
Quarters Held
4
currently held

Position History AVIR

Reported value by quarter
Q4 ’22: $6MQ4 ’22Q1 ’23: $4MQ1 ’23Q2 ’23: $5MQ2 ’23Q3 ’23: $4MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20231.26M$4M+35.90%
Q2 20231.26M$5M+33.11%
Q1 20231.26M$4M+24.86%
Q4 20221.26M$6M+13.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tyrus Capital S.a.m.’s full portfolio or all institutional holders of AVIR.